A collaboration of researchers has developed a testing method for methylome sequencing of cell-free DNA that accurately detects and locates certain types of early-stage cancer, study results published in Nature Communications showed.
The newly developed screening procedure involves a novel methylome assay to sequence cell-free DNA in patients’ blood plus a computational model to gather information from DNA sequencing to assist researchers in early detection and diagnosis of tumors.
The process offers an approximate 12-fold cost savings over currently available DNA sequencing, the